AFT Pharmaceuticals Ltd. has licensed the product line of its patented combination painkiller, Maxigesic, in the Nordic region to Weifa AS. Maxigesic consists of a patented fixed ratio of ibuprofen and paracetamol (also called acetaminophen) for pain management. Maxigesic products will cover tablet, sachet and oral liquid formulations.